Wire Stories
-
420City of Brawley, CA Selects PortalGuard� Identity and Access Management Cloud Platform for Enhanced Web Application and Workstation Security
BRAWLEY, Calif. and WALL, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and...
-
532Gilat Announces Availability of SkyEdge IV Taurus-M,�New Satellite Modem for Military and Government Markets
SkyEdge IV Taurus-M is backward compatible to SkyEdge II-c, providing investment protection and answering market demands for the smallest high-performance, rugged modem...
-
374WP Engine�s Fourth Annual DE{CODE} Conference Doubles Registrations Fueling Interest in Open Source Innovation
The future of headless, advances in eCommerce, and the next generation of builder tools will take center stage at this year�s global...
-
1.0KElpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of First-in-Class Anti-CD39xTGF-? Bispecific Antibody ES014
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.–(BUSINESS WIRE)–Elpiscience Biopharmaceuticals, Inc. (�Elpiscience�), a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for...
-
429HCLTech launches suite of technology solutions for 5G and beyond
NOIDA, India & BARCELONA, Spain–(BUSINESS WIRE)–#5G–HCLTech, a leading global technology company, launched a range of innovative technology solutions for the 5G ecosystem...
-
402BeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
Recorded product revenue of $339.0 million and $1.3 billion for the fourth quarter and full year, respectively, increasing 72.3% and 97.9% from...
-
547Nickel 28 Releases Ramu Q4 and Full Year 2022 Operating Performance
TORONTO–(BUSINESS WIRE)–$NKL #mining–Nickel 28 Capital Corp. (�Nickel 28� or the �Company�) (TSXV: NKL) (FSE: 3JC0) is pleased to provide an update on...
-
421Dr. Reddy’s Laboratories Announces Agreement to Acquire Mayne Pharma�s U.S. Generic Prescription Product Portfolio
HYDERABAD, India & BASEL, Switzerland & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #DRREDDY–Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy�s Laboratories Ltd. (BSE: 500124,...
-
373Biocytogen�s Subsidiary Eucure Biopharma and Chipscreen Biosciences� Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008
BEIJING–(BUSINESS WIRE)–#Biocytogen–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that its wholly owned subsidiary, Eucure (Beijing) Biopharma Co., Ltd. (�Eucure...
-
448China Performs First Cancer Patient Treatments in the Xiamen Humanity Hospital Using Novel Accelerator-based Radiation Oncology Therapy (BNCT)
Neuboron develops an advanced in-hospital NeuPex AB-BNCT medical system for clinical use at XHH Research Center. XIAMEN, China–(BUSINESS WIRE)–Neuboron Medical Group (NMG),...
